SARS-CoV-2 Rapid Antigen Test Based on a New Anti-Nucleocapsid Protein Monoclonal Antibody: Development and Real-Time Validation

SARS-CoV-2 Rapid Antigen Test Based on a New Anti-Nucleocapsid Protein Monoclonal Antibody: Development and Real-Time Validation

SARS-CoV-2 diagnostic tests have become an important tool for pandemic control. Among the alternatives for COVID-19 diagnosis, antigen rapid diagnostic tests (Ag-RDT) are very convenient and widely used. However, as SARS-CoV-2 variants may continuously emerge, the replacement of tests and reagents m...

Full description

Bibliographic Details
Main Authors: Fabiana Fioravante Coelho, Miriam Aparecida da Silva, Thiciany Blener Lopes, Juliana Moutinho Polatto, Natália Salazar de Castro, Luis Adan Flores Andrade, Karine Lima Lourenço, Hugo Itaru Sato, Alex Fiorini de Carvalho, Helena Perez Coelho, Flávia Fonseca Bagno, Daniela Luz, Vincent Louis Viala, Pedro Queiroz Cattony, Bruna de Sousa Melo, Ana Maria Moro, Wagner Quintilio, Ana Paula Barbosa, Camila Gasque Bomfim, Camila Pereira Soares, Cristiane Rodrigues Guzzo, Flavio Guimarães Fonseca, Edison Luiz Durigon, Ricardo Tostes Gazzinelli, Santuza M. Ribeiro Teixeira, Roxane Maria Fontes Piazza, Ana Paula Fernandes
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Microorganisms
Subjects:
SARS-CoV-2
diagnosis
nucleocapsid (N) antigen
IgG2b monoclonal antibody
Ag-RDT development
validation
Online Access:https://www.mdpi.com/2076-2607/11/10/2422

Internet

https://www.mdpi.com/2076-2607/11/10/2422

Similar Items